Drug Utilization Review (DUR) is designed to improve the quality of pharmaceutical care by ensuring that prescriptions are appropriate, medically necessary and unlikely to result in adverse medical outcomes. Medicaid’s DUR program includes prospective, online and retrospective review as well as use of standards developed by the National Council for Prescription Drug Programs (NCPDP). A board comprised of physicians and pharmacists provides guidance to Agency staff.
About the Board
Board Meetings
July 24,2024 Agenda
This is a meeting of Alabama Medicaid’s Drug Utilization Review Board in which Prospective and Retrospective Drug Utilization Review are reviewed. The DUR program is designed to educate physicians and pharmacists to identify and reduce the frequency of patterns of fraud, abuse, gross overuse, or inappropriate or medically unnecessary care among physicians and pharmacists.
As the Alabama State of Emergency has been lifted, the July 24, 2024 Drug Utilization Review (DUR) Board Meeting will be held in person at the Alabama Medicaid building in Montgomery, Alabama. Voting Board members must be present to count toward a quorum. A virtual WebEx option will be available on the Medicaid website for the public to attend/observe the meeting, please find the link below. All meetings of this Committee are open to the public.
Alabama Medicaid DUR Meeting
July 24, 2024
1:00pm Central Time
|
Join by meeting number
|
|
Meeting number (access code): 2663 625 5567
|
|
Meeting password: u3yT2CZnZj8
|
|
|
Tap to join from a mobile device (attendees only)
+1-650-479-3208,,26636255567## United States Toll
Join by phone
+1-650-479-3208 United States Toll
DUR Board Minutes 2017-2024